rs33922842

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_000518.5(HBB):​c.130G>T​(p.Glu44Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

HBB
NM_000518.5 stop_gained

Scores

2
3
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:10

Conservation

PhyloP100: -0.219
Variant links:
Genes affected
HBB (HGNC:4827): (hemoglobin subunit beta) The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 239 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-5226762-C-A is Pathogenic according to our data. Variant chr11-5226762-C-A is described in ClinVar as [Pathogenic]. Clinvar id is 15406.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-5226762-C-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HBBNM_000518.5 linkuse as main transcriptc.130G>T p.Glu44Ter stop_gained 2/3 ENST00000335295.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HBBENST00000335295.4 linkuse as main transcriptc.130G>T p.Glu44Ter stop_gained 2/31 NM_000518.5 P1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000398
AC:
1
AN:
251398
Hom.:
0
AF XY:
0.00000736
AC XY:
1
AN XY:
135860
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Cov.:
36
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.00000756

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:4
Pathogenic, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoAug 19, 2021The c.130G>T (p.Glu44*) pathogenic variant (also known as Codon 43 (G>T)) causes the premature termination of beta globin protein synthesis, and is associated with beta(0)-thalassemia PMIDs: 3403716 (1988), 17008283 (2006), 25000193 (2014)). -
Pathogenic, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesFeb 08, 2018The HBB c.130G>T; Glu43Ter variant (rs33922842), also known as Codon 43 (G>T), is reported in the medical literature in an individual with beta thalassemia who also carried an additional nonsense variant on the opposite chromosome (Atweh 1988, see link to HbVar below). The variant is described as pathogenic in the ClinVar database (Variation ID: 15406). The variant is also listed in the Genome Aggregation Database in 1 out of 246166 alleles. This variant introduces a premature termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. In agreement with that prediction, this variant is shown to have reduced mRNA levels when transfected and absent mRNA levels in cells derived from the individual who carried this variant and an additional nonsense variant on the opposite chromosome (Athweh 1988). Considering available information, this variant is classified as pathogenic. References: Link to Glu43Ter in HbVar database: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=853&.cgifields=histD Atweh GF et al. New amber mutation in a beta-thalassemic gene with nonmeasurable levels of mutant messenger RNA in vivo. J Clin Invest. 1988 Aug;82(2):557-61. -
Pathogenic, criteria provided, single submitterclinical testingGeneDxFeb 04, 2022Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30275481, 31690135, 3403716, 17008283) -
Pathogenic, criteria provided, single submitterclinical testingInvitaeOct 06, 2023This sequence change creates a premature translational stop signal (p.Glu44*) in the HBB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HBB are known to be pathogenic (PMID: 23637309). This variant is present in population databases (rs33922842, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with beta-thalassemia (PMID: 3403716, 25089872). This variant is also known as p.Glu43*. ClinVar contains an entry for this variant (Variation ID: 15406). For these reasons, this variant has been classified as Pathogenic. -
beta Thalassemia Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingCounsylFeb 24, 2017- -
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Oct 19, 2020- -
Pathogenic, no assertion criteria providedcurationThe ITHANET community portal, The Cyprus Institute of Neurology and GeneticsNov 25, 2019- -
Beta zero thalassemia Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMAug 01, 1988- -
Hemoglobinopathy Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpNov 14, 2017Variant summary: The HBB c.130G>T (p.Glu44X) variant results in a premature termination codon, predicted to cause a truncated or absent HBB protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.176delC, c.217dupA, c.287dupA, etc.). This variant was found in 1/246166 control chromosomes at a frequency of 0.0000041 (gnomAD), which does not exceed the estimated maximal expected allele frequency of a pathogenic HBB variant (0.0111803). This variant has been found three Chinese BTHAL patients in compound heterozygous state with other pathogenic variants (Atwen_1988, Tan_2006). Two of them were BTHAL major patients who carried this variant in compound heterozygous state with c.127_130delCTTT. In addition, several BTHAL minor individuals who carry this variant in heterozygous state have been reported (Lin_2014, He_2017). The carrier frequency in a large Chinese population was 0.03% (He_2017). A functional analysis showed that the mutant mRNA in vivo must be extremely low (Atwen_1988). Multiple clinical diagnostic laboratories/reputable databases have classified this variant as pathogenic. Taken together, this variant is classified as pathogenic. -
Hb SS disease Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingBaylor Genetics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.49
D
BayesDel_noAF
Pathogenic
0.44
CADD
Pathogenic
36
DANN
Uncertain
1.0
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Benign
0.24
N
MutationTaster
Benign
1.0
A
Vest4
0.71
GERP RS
4.2

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs33922842; hg19: chr11-5247992; API